251 related articles for article (PubMed ID: 21565858)
1. Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.
Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
J Clin Pathol; 2011 Sep; 64(9):756-60. PubMed ID: 21565858
[TBL] [Abstract][Full Text] [Related]
2. Cinacalcet upregulates calcium-sensing receptors of parathyroid glands in hemodialysis patients.
Sumida K; Nakamura M; Ubara Y; Marui Y; Tanaka K; Takaichi K; Tomikawa S; Inoshita N; Ohashi K
Am J Nephrol; 2013; 37(5):405-12. PubMed ID: 23594726
[TBL] [Abstract][Full Text] [Related]
3. Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
Ichii M; Ishimura E; Okuno S; Chou H; Kato Y; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
Nephron Clin Pract; 2010; 115(3):c195-202. PubMed ID: 20413997
[TBL] [Abstract][Full Text] [Related]
4. Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?
Lomonte C; Vernaglione L; Chimienti D; Bruno A; Cocola S; Teutonico A; Cazzato F; Basile C
Clin J Am Soc Nephrol; 2008 May; 3(3):794-9. PubMed ID: 18322048
[TBL] [Abstract][Full Text] [Related]
5. Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?
Kakuta T; Tanaka R; Kanai G; Sawaya A; Hirukawa T; Sato A; Saito A
Ther Apher Dial; 2009 Oct; 13 Suppl 1():S20-7. PubMed ID: 19765255
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism.
Meola M; Petrucci I; Barsotti G
Nephrol Dial Transplant; 2009 Mar; 24(3):982-9. PubMed ID: 19181759
[TBL] [Abstract][Full Text] [Related]
7. Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients.
Hirai T; Nakashima A; Takasugi N; Yorioka N
Ther Apher Dial; 2010 Dec; 14(6):577-82. PubMed ID: 21118366
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
Torres PU
J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
[TBL] [Abstract][Full Text] [Related]
9. Histology and immunohistochemistry of the parathyroid glands in renal secondary hyperparathyroidism refractory to vitamin D or cinacalcet therapy.
Vulpio C; Bossola M; Di Stasio E; Tazza L; Silvestri P; Fadda G
Eur J Endocrinol; 2013 Jun; 168(6):811-9. PubMed ID: 23520248
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet induces apoptosis in parathyroid cells in patients with secondary hyperparathyroidism: histological and cytological analyses.
Tatsumi R; Komaba H; Kanai G; Miyakogawa T; Sawada K; Kakuta T; Fukagawa M
Nephron Clin Pract; 2013; 124(3-4):224-31. PubMed ID: 24503607
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid gland ultrasound patterns and biochemical findings after one-year cinacalcet treatment for advanced secondary hyperparathyroidism.
Vulpio C; Bossola M; De Gaetano A; Maresca G; Di Stasio E; Zagaria L; Luciani G; Giordano A; Castagneto M
Ther Apher Dial; 2010 Apr; 14(2):178-85. PubMed ID: 20438540
[TBL] [Abstract][Full Text] [Related]
12. Regression of parathyroid gland swelling by treatment with cinacalcet.
Terawaki H; Nakano H; Takeguchi F; Hasegawa T; Nakayama M; Okazaki M; Hosoya T
Nephrol Dial Transplant; 2009 Feb; 24(2):690-1; author reply 691-2. PubMed ID: 18987257
[No Abstract] [Full Text] [Related]
13. Paricalcitol and cinacalcet have disparate actions on parathyroid oxyphil cell content in patients with chronic kidney disease.
Ritter C; Miller B; Coyne DW; Gupta D; Zheng S; Brown AJ; Slatopolsky E
Kidney Int; 2017 Nov; 92(5):1217-1222. PubMed ID: 28750928
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid pathology in hyperparathyroidism secondary to chronic renal failure.
Malmaeus J; Grimelius L; Johansson H; Akerström G; Ljunghall S
Scand J Urol Nephrol; 1984; 18(2):157-66. PubMed ID: 6379860
[TBL] [Abstract][Full Text] [Related]
15. Parathyroidectomy for secondary hyperparathyroidism in the era of calcimimetics.
Tominaga Y; Matsuoka S; Uno N; Sato T
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S21-6. PubMed ID: 19032523
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
18. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
Miller G; Davis J; Shatzen E; Colloton M; Martin D; Henley CM
Nephrol Dial Transplant; 2012 Jun; 27(6):2198-205. PubMed ID: 22036941
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of cinacalcet hydrochloride for hemodialysis patients with severe secondary hyperparathyroidism in Japan.
Komaba H; Moriwaki K; Goto S; Yamada S; Taniguchi M; Kakuta T; Kamae I; Fukagawa M
Am J Kidney Dis; 2012 Aug; 60(2):262-71. PubMed ID: 22445709
[TBL] [Abstract][Full Text] [Related]
20. Clinical issues regarding cinacalcet hydrochloride in Japan.
Yokoyama K
Ther Apher Dial; 2009 Oct; 13 Suppl 1():S12-4. PubMed ID: 19765252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
